Literature DB >> 27142487

Lessons learned from the cystic fibrosis pig.

David K Meyerholz1.   

Abstract

Deficient function in the anion channel cystic fibrosis (CF) transmembrane conductance regulator is the fundamental cause for CF. This is a monogenic condition that causes lesions in several organs including the respiratory tract, pancreas, liver, intestines, and reproductive tract. Lung disease is most notable, given it is the leading cause of morbidity and mortality in people with CF. Shortly after the identification of CF transmembrane conductance regulator, CF mouse models were developed that did not show spontaneous lung disease as seen in humans, and this spurred development of additional CF animal models. Pig models were considered a leading choice for several reasons including their similarity to humans in respiratory anatomy, physiology, and in size for translational imaging. The first CF pig models were reported in 2008 and have been extremely valuable to help clarify persistent questions in the field and advance understanding of disease pathogenesis. Because CF pigs are susceptible to lung disease like humans, they have direct utility in translational research. In addition, CF pig models are useful to compare and contrast with current CF mouse models, human clinical studies, and even newer CF animal models being characterized. This "triangulation" strategy could help identify genetic differences that underlie phenotypic variations, so as to focus and accelerate translational research.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; CFTR; Cystic fibrosis; Lung disease; Pig model

Mesh:

Substances:

Year:  2016        PMID: 27142487      PMCID: PMC4885762          DOI: 10.1016/j.theriogenology.2016.04.057

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  55 in total

Review 1.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

2.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

4.  Cftr controls lumen expansion and function of Kupffer's vesicle in zebrafish.

Authors:  Adam Navis; Lindsay Marjoram; Michel Bagnat
Journal:  Development       Date:  2013-03-13       Impact factor: 6.868

5.  Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Authors:  Guido Veit; Radu G Avramescu; Doranda Perdomo; Puay-Wah Phuan; Miklos Bagdany; Pirjo M Apaja; Florence Borot; Daniel Szollosi; Yu-Sheng Wu; Walter E Finkbeiner; Tamas Hegedus; Alan S Verkman; Gergely L Lukacs
Journal:  Sci Transl Med       Date:  2014-07-23       Impact factor: 17.956

6.  Tracheomalacia is associated with lower FEV1 and Pseudomonas acquisition in children with CF.

Authors:  Anthony J Fischer; Sachinkumar B Singh; Ryan J Adam; David A Stoltz; Christopher F Baranano; Simon Kao; Miles M Weinberger; Paul B McCray; Timothy D Starner
Journal:  Pediatr Pulmonol       Date:  2013-10-25

7.  Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model.

Authors:  Andrea E Potash; Tanner J Wallen; Philip H Karp; Sarah Ernst; Thomas O Moninger; Nicholas D Gansemer; David A Stoltz; Joseph Zabner; Eugene H Chang
Journal:  Mol Ther       Date:  2013-03-19       Impact factor: 11.454

8.  Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.

Authors:  David A Stoltz; David K Meyerholz; Alejandro A Pezzulo; Shyam Ramachandran; Mark P Rogan; Greg J Davis; Robert A Hanfland; Chris Wohlford-Lenane; Cassie L Dohrn; Jennifer A Bartlett; George A Nelson; Eugene H Chang; Peter J Taft; Paula S Ludwig; Mira Estin; Emma E Hornick; Janice L Launspach; Melissa Samuel; Tatiana Rokhlina; Philip H Karp; Lynda S Ostedgaard; Aliye Uc; Timothy D Starner; Alexander R Horswill; Kim A Brogden; Randall S Prather; Sandra S Richter; Joel Shilyansky; Paul B McCray; Joseph Zabner; Michael J Welsh
Journal:  Sci Transl Med       Date:  2010-04-28       Impact factor: 17.956

9.  Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.

Authors:  Aliye Uc; Alicia K Olivier; Michelle A Griffin; David K Meyerholz; Jianrong Yao; Maisam Abu-El-Haija; Katherine M Buchanan; Oriana G Vanegas Calderón; Marwa Abu-El-Haija; Alejandro A Pezzulo; Leah R Reznikov; Mark J Hoegger; Michael V Rector; Lynda S Ostedgaard; Peter J Taft; Nick D Gansemer; Paula S Ludwig; Emma E Hornick; David A Stoltz; Katie L Ode; Michael J Welsh; John F Engelhardt; Andrew W Norris
Journal:  Clin Sci (Lond)       Date:  2015-01       Impact factor: 6.124

Review 10.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

View more
  6 in total

1.  A novel swine model of the acute respiratory distress syndrome using clinically relevant injury exposures.

Authors:  Mohamad H Tiba; Brendan M McCracken; Danielle C Leander; Carmen I Colmenero; Jean A Nemzek; Michael W Sjoding; Kristine E Konopka; Thomas L Flott; J Scott VanEpps; Rodney C Daniels; Kevin R Ward; Kathleen A Stringer; Robert P Dickson
Journal:  Physiol Rep       Date:  2021-05

Review 2.  Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.

Authors:  Anjali Y Bhagirath; Yanqi Li; Deepti Somayajula; Maryam Dadashi; Sara Badr; Kangmin Duan
Journal:  BMC Pulm Med       Date:  2016-12-05       Impact factor: 3.317

Review 3.  Best practices in the treatment of early cystic fibrosis lung disease.

Authors:  Marijke Proesmans
Journal:  Ther Adv Respir Dis       Date:  2016-12-02       Impact factor: 4.031

4.  Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic.

Authors:  Martin Donnelley; David W Parsons
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

5.  Preclinical Modeling for Therapeutic Development in Cystic Fibrosis.

Authors:  Tracey L Bonfield
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

Review 6.  The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.

Authors:  Marta Stolarczyk; Bob J Scholte
Journal:  Mediators Inflamm       Date:  2018-01-09       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.